Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • News
  • Industry
  • Pharma News
  • NPPA fixes retail...

NPPA fixes retail price of 12 formulations, Details

Medical Dialogues TeamWritten by Medical Dialogues Team Published On 2021-06-06T11:30:54+05:30  |  Updated On 13 Oct 2023 5:05 PM IST
NPPA fixes retail price of 12 formulations, Details
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email

New Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India, has fixed the retail price of 12 formulations, including those used to treat angina pectoris, high blood pressure, human immunodeficiency virus (HIV) infection, and type 2 diabetes.

These include Archimedis Healthcare and Lupin's Ivabradine Hydrochloride and Metoprolol Tartrate combination tablet which is used in the treatment of Angina, Ravenbhel/Neomac Pharmaceutical's Telmisartan, Cilnidipine & Metoprolol (ER) fixed dose combination tablet that helps to lower high blood pressure and prevent stroke and heart attack.

In addition to this, the list also includes Skymap Pharmaceutical's antibiotic combination Doxycycline & Lactic Acid Bacillus Capsule, Hetero/Cipla's antiviral drug combination Darunavir and Ritonavir tablet, Stedman Pharmaceutical's Povidone-Iodine gargle 0.5% w/v .

Further, the list contains the popular anti-diabetic drug combination Teneligliptin and Metformin HCL Tablet marketed by Morepen Laboratories and Abbott Healthcare.

Also Read: NPPA panel pegs price of Hetero Labs HIV drug Darunavir Ethanolate at Rs 190.44 per tablet

This price fixation is followed by the decisions made by the National Pharmaceutical Pricing Authority at its 87th Authority meeting held on 27th of May 2021, where the Authority discussed retail price fixation of new drugs falling under the purview of Para 2 (u) of DPCO, 2013 and approved the retail prices of new drugs under Para 5 and 15 of the DPCO 2013.

This comes after in exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S. O. 701(E) dated 10th March, 2016 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA), fixed, the price as specified in column (6) of the table herein below as the retail price, exclusive of goods and services tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof;

Sl.

No.

Name of the

Formulation / Brand Name

Strength

Unit

Manufacturer &

Marketing Company

Retail

Price (Rs.)

(1)

(2)

(3)

(4)

(5)

(6)

1.

Ivabradine Hydrochloride

+ Metoprolol Tartrate Tablet

Each film coated tablet contains: Ivabradine Hydrochloride eq. to Ivabradine 5 mg + Metoprolol Tartrate IP 25 mg

1 Tablet

M/s Archimedis Healthcare Pvt. Ltd.

/ M/s Lupin Limited

15.75

2.

Ivabradine Hydrochloride

+ Metoprolol Tartrate Tablet

Each film coated tablet contains: Ivabradine Hydrochloride eq. to

Ivabradine 5 mg + Metoprolol Tartrate IP 50 mg

1 Tablet

M/s Archimedis Healthcare Pvt. Ltd.

/ M/s Lupin Limited

18.14

3.

Telmisartan, Cilnidipine & Metoprolol (ER) Tablet

Each film coated tablet contains: Telmisartan IP 40mg, Cilnidipine IP 10mg

Metoprolol Succinate IP 23.75mg eq. to Metoprolol Tartrate (as extended release) 25mg

1 Tablet

M/s Ravenbhel Healthcare Pvt. Ltd.

/ M/s Neomac Pharmaceuticals Pvt. Ltd.

10.16

4.

Telmisartan, Cilnidipine & Metoprolol (ER) Tablet

Each film coated tablet contains: Telmisartan IP 40mg, Cilnidipine IP 10mg

Metoprolol Succinate IP 47.50mg eq. to Metoprolol Tartrate (as extended release) 50mg

1 Tablet

M/s Ravenbhel Healthcare Pvt. Ltd.

/ M/s Neomac Pharmaceuticals Pvt. Ltd.

12.41

5.

Doxycycline & Lactic Acid Bacillus Capsule

Each hard gelatine capsule contains: Doxycycline hyclate IP eq. to Doxycycline (as pellets) 100mg

Lactic Acid Bacillus (As enteric coated pellets) 5 Billion Spores

1

Capsule

M/s Skymap Pharmaceuticals Pvt. Ltd.

6.94

6.

Doxycycline & Lactic Acid Bacillus Capsule

Each hard gelatine capsule contains: Doxycycline hyclate IP eq. to Doxycycline (as pellets) 100mg

Lactic Acid Bacillus (As enteric coated pellets) 5 Billion Spores

1

Capsule

M/s Skymap Pharmaceuticals Pvt. Ltd. / M/s

Glensmith Labs Pvt. Ltd.

6.94

7.

Darunavir + Ritonavir Tablet

Each film coated tablet contains: Darunavir Ethanolate eq. Darunavir IP 600mg

Ritonavir IP 100mg

1 Tablet

M/s Hetero Labs Ltd.

/ M/ Cipla Limited

145.70

8.

Povidone-Iodine gargle 0.5% w/v

Contains:

Povidone Iodine IP 0.5% w/v (available Iodine 0.05% w/v)

1 ML

M/s Stedman

Pharmaceuticals Pvt. Ltd.

0.66

9.

Teneligliptin + Metformin HydrochlorideIP (SR) Tablet

Each uncoated bilayered tablet contains:

Teneligliptin Hydrobromide Hydrate eq. to Teneligliptin 20mg

Metformin HydrochlorideIP (As

1 Tablet

M/s Windlas Biotech Pvt. Limited / M/s Abbott Healthcare Limited

11.00

Sl.

No.

Name of the

Formulation / Brand Name

Strength

Unit

Manufacturer &

Marketing Company

Retail

Price (Rs.)

(1)

(2)

(3)

(4)

(5)

(6)

Sustained Release) IP 500mg

10.

Teneligliptin + Metormin HCL (ER) Tablet

Each uncoated bilayered tablet contains:

Teneligliptin Hydrobromide Hydrate eq. to Teneligliptin 20mg

Metformin hydrochloride (As Extended Release) IP 500mg

1 Tablet

M/s Morepen Laboratories Limited

10.96

11.

Teneligliptin + Metormin HCL (ER) Tablet

Each uncoated bilayered tablet contains:

Teneligliptin Hydrobromide Hydrate eq. to Teneligliptin 20mg

Metformin hydrochloride (As Extended Release) IP 1000mg

1 Tablet

M/s Morepen Laboratories Limited

11.48

12.

Teneligliptin + Metformin Hydrochloride IP (SR) Tablet

Each uncoated bilayered tablet contains:

Teneligliptin Hydrobromide Hydrate eq. to Teneligliptin 20mg

Metformin HydrochlorideIP (As Sustained Release) IP 1000mg

1 Tablet

M/s Windlas Biotech Pvt. Limited / M/s Abbott Healthcare Limited

11.48

The notification further added;

(a) The manufacturer of above mentioned formulations i.e. "new drug" under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.

(b) The manufacturer may add goods and services tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above said table.

(c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.

(d) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.

(e) The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned above i.e. who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/marketing companies.

(f) In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.

(g) Consequent to the issue of ceiling price of such formulation as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s) superseded.

Also Read:NPPA panel suggests price Of Ivabradine Hydrochloride tablet marketed by Lupin
nppaIvabradinemetoprololDarunavirritonavirDoxycyclinpovidone-iodineMetforminteneligliptinciplaheteroAbbottlupinprice fixation
Medical Dialogues Team
Medical Dialogues Team
    Show Full Article
    Next Story

    Editorial

    Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Breast Cancer - Dr Aditya Murali

    Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Breast Cancer...

    Aspirin in Primary Prevention- When to Consider?

    Aspirin in Primary Prevention- When to Consider?

    Featured image representing medico legal

    What's the Role of Expert Opinion in Medical Negligence?

    7- Point Discharge Protocol for AECOPD: Time to Inculcate in Practice

    7- Point Discharge Protocol for AECOPD: Time to Inculcate in Practice

    Aspirin Use in Women Aged 40-50 with Diabetes and Hypertension: Identifying the Ideal Candidates

    Aspirin Use in Women Aged 40-50 with Diabetes and Hypertension: Identifying the Ideal Candidates

    View All

    Journal Club Today

    Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Breast Cancer - Dr Aditya Murali

    Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Breast Cancer...

    View All

    Health News Today

    Health Bulletin 09/ May/ 2025

    Health Bulletin 09/ May/ 2025

    View All
    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok